1. Market Research
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
Global Human Growth Hormone Drugs Industry

Global Human Growth Hormone Drugs Industry

  • June 2021
  • 283 pages
  • ID: 5443628
  • Format: PDF
  • Global Industry Analysts

Summary

Table of Contents

MARKET IMPACT SURVEY - COVID-19 & LOOMING RECESSION

Timely market intelligence is paramount in these uncertain times!

We launched an impact survey to update this project with timely insights during 2020. Update frequency will depend upon evolving market conditions and executive opinions. Our participants are executives driving strategy, marketing, sales and product management at competitive companies worldwide. All updates during the rest of the year are complimentary to clients!

Abstract:

Global Human Growth Hormone Drugs Market to Reach $4 Billion by 2026

The human growth hormone, which is also known as somatropin, is a peptide hormone that is secreted by pituitary gland, which regulates cell regeneration, cell growth, metabolism, and reproduction. The level of growth hormones should be optimum in human body for normal growth. It can be regulated by several factors such as sleep, stress, exercise, and lower levels of glucose. Human growth hormones help to control body composition, bone and muscle growth, sugar and fat metabolism, recovery from injuries, and body fluids. They also help in boosting muscle strength and performance. Improper levels of growth hormones may affect the quality of life, intensifying the risks of health disorders such as high levels of cholesterol, decreased bone density, and deficiency in growth hormones. While lower levels of the growth hormones result in fat accumulation in the human body, higher levels result in gigantism in children and short bowel syndrome and muscle-wasting disease in adults. With growing age, the human growth hormone levels decrease. This natural process of slowing down of the growth hormone production in human body has raised the interest in synthetic hormone therapies globally.

Amid the COVID-19 crisis, the global market for Human Growth Hormone Drugs estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2026, growing at a CAGR of 3.5% over the analysis period. Subcutaneous, one of the segments analyzed in the report, is projected to grow at a 4% CAGR to reach US$2.7 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Intramuscular segment is readjusted to a revised 3.1% CAGR for the next 7-year period. This segment currently accounts for a 23.7% share of the global Human Growth Hormone Drugs market.

The U.S. Market is Estimated at $1.3 Billion in 2021, While China is Forecast to Reach $285.1 Million by 2026

The Human Growth Hormone Drugs market in the U.S. is estimated at US$1.3 Billion in the year 2021. The country currently accounts for a 40.12% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$285.1 Million in the year 2026 trailing a CAGR of 5.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3% CAGR while Rest of European market (as defined in the study) will reach US$299.1 Million by the close of the analysis period.

The market is expected to witness growth owing to surge in cases related to pituitary dysfunction, and increasing number of health disorders in children, mainly owing to changes in food habits. Some other major factors that have been driving the market growth are advancement of recombinant HGH drugs, and increasing off-label use of human growth hormones. Also, increase in awareness with regards to treatment processes; increasing aging population; increasing neuropsychiatric cases; increasing funds by governments for research and development within the endocrinology sector; introduction of technological advancements within the healthcare sector for enhancing quality of services; increasing rate of consumption of the drugs in key applications. Additionally, initiatives adopted by private and public organizations for promoting healthcare-related policies and services in the under-developing and developed companies is also boosting market for human growth hormones globally. Also, demand from people for effective treatment processes and rise in disposable income among the urban population is likely to offer market growth opportunities. Increasing prevalence of adopting latest technologies in regards to pill production at low cost is also likely to positively impact market demand for human growth hormones. Increased FDA approvals are offering immense opportunities to companies for developing new, more effective drugs, with lesser side effects. The market will also benefit from increasing number of health disorders in children, mainly owing to changes in food habits. Also, increase in awareness in regards to treatment processes; increasing aging population; increasing neuropsychiatric cases; increasing funds by governments for research and development within the endocrinology sector; introduction of technological advancements within the healthcare sector for enhancing quality of services; increasing rate of consumption of the drugs in key applications; increasing approvals by FDA along with other government organizations; as well as increase in research organizations pertaining to the biotechnology field is driving market growth. Additionally, initiatives adopted by private and public organizations for promoting healthcare-related policies and services in the under-developing and developed companies is also boosting market for human growth hormones globally.

Intravenous Segment to Reach $304.8 Million by 2026

In the global Intravenous segment, USA, Canada, Japan, China and Europe will drive the 2.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$231.8 Million in the year 2020 will reach a projected size of US$269.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$14.4 Million by the year 2026.

Select Competitors (Total 46 Featured)
  • AnkeBio Co. Ltd
  • Eli Lilly and Company
  • EMD Serono Inc.
  • Ferring Pharmaceuticals
  • Genentech, Inc (Roche)
  • GeneScience Pharmaceuticals Co. Ltd
  • Ipsen S.A.
  • LG Life Sciences
  • Merck KGaA
  • Novo Nordisk A/S
  • Pfizer, Inc
  • Sandoz International GmbH (Novartis AG)
  • Strongbridge Biopharma
  • Teva Pharmaceutical Industries, Ltd

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • € 2016
  • August 2021
  • 143 pages

The global human growth hormone market exhibited strong growth during 2015-2020. HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. The hormone ...

  • World
  • Human Growth Hormone
  • Industry analysis

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on